CromaPharma 050 FillMaxWzkxMCw5MTBd

Croma-Pharma: First company worldwide to achieve MDR approval in the aesthetic field

  • “saypha® RICH“ is the first dermal filler to meet the strict requirements of the EU Medical Device Regulation for aesthetic treatments (MDR Annex XVI)
  • Approval as a guarantee for product quality, patient safety and efficiency
  • Milestone in Croma's corporate history and global growth strategy

Wenn Sie ein Arzt sind, melden Sie sich bitte an, um spezifische Informationen über unsere Produkte zu erhalten.



* Felder sind Pflichtfelder